Skip to content

Study of IADADEMSTAT for the Treatment of Sickle Cell Disease.

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521838-29-00
Acronym
CL05-ORY-1001
Enrollment
30
Registered
2025-08-20
Start date
2025-10-16
Completion date
Unknown
Last updated
2025-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Disease

Interventions

None listed

Sponsors

Oryzon Genomics S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026